Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC Norfolk prospective population cohort.

Tinka J van TrierMarjolein SnaterseS Matthijs BoekholdtWilma J M Scholte Op ReimerSteven H J HagemanFrank L J VisserenJannick A N DorresteijnRon J G PetersHarald T Jørstad

Published in: European journal of preventive cardiology (2023)

In a UK population cohort, the SCORE2 low-risk model showed fair discrimination and calibration, with clinical benefit for preventive treatment initiation decisions. In contrast, in individuals aged 70-79 years, SCORE2-OP demonstrated poor discrimination, underestimated risk in both sexes, and limited clinical utility.

Keyphrases

coronary artery disease
magnetic resonance
coronary artery
community dwelling
atrial fibrillation
low cost
aortic stenosis